by Ethan Huff, NewsTarget:
The hundreds of grants and investments totaling at least $132 million that were earmarked by the FTX Foundation and its FTX Future Fund for use in developing new bioweapons, “vaccines” and other chemical and pharmaceutical products are officially null and void. And their recipients are now in a panic about it.
Following the announced resignation of the entire Future Fund leadership team on November 11, one of the companies that was supposed to receive a cash grant from it, SecureBio, lamented the fact that employees at his firm will now be out of a job unless emergency backup funding is procured.